{"nct_id":"NCT01203917","title":"Efficacy, Safety, Tolerability of Gefitinib as 1st Line in Caucasian Patients With EGFR Mutation Positive Advanced NSCLC","status":"COMPLETED","status_verified_date":"2016-11","start_date":"2010-09","start_date_type":null,"primary_completion_date":"2012-08","primary_completion_date_type":"ACTUAL","completion_date":"2016-06","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AZN"]}